Packaged food attribute data The FoodSwitch database holds detailed nutrition and attribute information on individual packaged food products. The data is used for research and advocacy to influence government policy and industry practice toward improved food environments. It is also used by the various apps to help consumers make healthier food choices by offering accessible and clear information about the nutritional content of packaged foods. The database is continually updated, reflecting changes in food formulations and the introduction of new products – it is estimated that there is around 25% - 30% of product churn every 12 months. The data is utilised in various tools and apps to guide users towards healthier eating patterns, supporting public health initiatives and research on dietary habits and nutrition. FoodSwitch: Tracking Food Data Across 17 Jurisdictions AustraliaNew ZealandUnited KingdomSwedenFranceUSAMexicoBrazilChile ChinaFijiHong KongIndiaKuwaitSouth A

Australians consume around 14 teaspoons of added sugar a day - two more than the 12 teaspoons limit recommended by the World Health Organisation (WHO). Eating too many foods high in added sugars can lead to weight gain, an increased risk of obesity related diseases, and is a major risk factor in tooth decay. What is sugar? Sugar is a type of carbohydrate that occurs naturally in foods such as milk and fruit and can also be added to foods and drinks in various forms by the manufacturer or the consumer. Total sugars of a product refers to the combination of sugars that are naturally present and those that are added.Intrinsic and milk sugars occur in foods and drinks such as intact fruits and vegetables (i.e. fructose) and milk (i.e. lactose).Added sugars are all other sugars. It is these sugars that are associated with poor health outcomes and we should avoid. They are often added by manufacturers to give greater sweetness or other desired characteristics. What is added sugar

The 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) co-sponsored by the World Health Organization will be held between 2nd-4th September 2024 at Taj Palace, New Delhi (India). This event will focus worldwide attention on safety and injury prevention. The event is hosted by The George Institute for Global Health in collaboration with three other WHO Collaborating Centres in the region:  Transportation Research and Injury Prevention Center (TRIP) at the Indian Institute of Technology (IIT) Delhi Department of Emergency Medicine, All India Institute for Medical Sciences (AIIMS) Department of Epidemiology, National Institute of Mental Health and Neuro Sciences (NIMHANS) All the international experts in the field will gather at this event with a united goal of “Building a safer future for all: Equitable and sustainable strategies for injury and violence prevention”. Why is the George Ins

At The George Institute, we are committed to improving our research by making it more relevant, responsive, translatable, and accountable to our communities, including patients, consumers, people with lived experiences, carers, civil society groups, and the public. These groups have a right to have a say in what is researched and how, and our aim is to ensure their involvement is a fundamental aspect of all our projects, wherever applicable and feasible. Meaningful involvement ensures that research questions are aligned with community needs, improves the relevance and usefulness of findings, and promotes a sense of ownership and understanding among community members. Additionally, it provides a platform for advocacy and increases the likelihood of research findings being used by policy makers. Ultimately, it empowers communities, fosters equitable partnerships, and drives positive social change. Our Framework for Community Engagement and Involvement was developed to establish a common

Program overview: Health and well-being are intrinsically impacted by socio-determinants related to carers, family, community, and service delivery across health and other sectors, within local country context. Socio-determinants are complex and can include dispossession, institutional racism, drug and alcohol, and debt, resulting in a lack of access to culturally safe services and intergenerational mistrust of services. However, sustainably integrating services within health and other sectors is challenging due to patient, organisational and policy and historical barriers.Our program aims to strengthen health systems resilience using interdisciplinary implementation research across different contexts, cultures and sectors, to holistically address socio-determinants of health so as to improve health equity. Program Objectives:  Examine and implement best practices in community engagement, partnerships and capacity-strengthening.  Embed WHO integrated people-centred

What are clinical trials? Clinical trials are research studies with humans, designed to test new treatments to find better ways to prevent, detect or treat disease1. Clinical trials are also sometimes referred to as interventional trials. The sorts of treatments being investigated include medicines or drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, and other items.2 Clinical trials rely on having members of the general public agree to take part. What happens in a clinical trial? In a clinical trial, participants meet with researchers who go through what the clinical trial will involve. All participants must be advised about the objectives of the research, what is expected of them, as well as any risks that may be experienced during and after the trial. Trials must follow a carefully controlled protocol, which is a plan that describes what researchers will do in the stu

Researchers at The George Institute for Global Health, UK, led by Executive Director Professor Otavio Berwanger, are spearheading a programme of work to transform that way we deliver large-scale clinical trials. This programme is borne out of a recognition of the limitations of the ‘traditional’ clinical trial model – and the health gains (social, environmental and economic) – to be had in investigating pragmatic, innovative and efficient approaches. In both the so-called ‘traditional’ and innovative trial models, the gold standard of randomisation controls for both known and unknown confounding factors that could influence trials outcomes, and represents the optimal method to work out whether a healthcare intervention reduces the risk of patient-important outcomes and so inform clinical practice. Where the two models differ is that the traditional approach requires participants be screened and recruited in a trial site by a team of investigators, and so demands both a

Soul Patts nurtures our future tech leaders to bring game-changing health solutions to life.

The George Institute’s founders are building on their pioneering vision with a transformational, million-dollar investment.